{"topic":{"slug":"mrna-cancer-vaccines","name":"mRNA Therapeutics & Cancer Vaccines","domain":"medicine","description":"Personalized neoantigen mRNA vaccines, lipid-nanoparticle delivery, self-amplifying and circular RNA and mRNA therapeutics beyond infectious disease.","keywords":["mRNA vaccine","lipid nanoparticle"],"paper_count":223,"latest_published":"2026-10-02","url":"https://space-kitty.com/topics/mrna-cancer-vaccines","api_url":"https://space-kitty.com/api/v1/topics/mrna-cancer-vaccines"},"dossier":null,"top_papers":[{"id":"doi:10.1038/s41586-023-06063-y","kind":"article","title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","authors":["Luis Alfonso Rojas","Zachary M. Sethna","Kevin C. Soares","Cristina Olcese","Nan Pang","Erin Patterson"],"author_count":51,"year":2023,"published":"2023-05-10","venue":"Nature","cited_by":1431,"doi":"10.1038/s41586-023-06063-y","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41586-023-06063-y","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41586-023-06063-y"},{"id":"doi:10.1186/s12943-021-01335-5","kind":"review","title":"mRNA vaccine for cancer immunotherapy","authors":["Lei Miao","Yu Zhang","Leaf Huang"],"author_count":3,"year":2021,"published":"2021-02-25","venue":"Molecular Cancer","cited_by":935,"doi":"10.1186/s12943-021-01335-5","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s12943-021-01335-5","archive_url":"https://space-kitty.com/papers/doi:10.1186/s12943-021-01335-5"},{"id":"doi:10.1038/s41586-024-08508-4","kind":"article","title":"RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer","authors":["Zachary M. Sethna","Pablo Guasp","Charlotte Reiche","Martina Milighetti","Nicholas Ceglia","Erin Patterson"],"author_count":47,"year":2025,"published":"2025-02-19","venue":"Nature","cited_by":334,"doi":"10.1038/s41586-024-08508-4","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41586-024-08508-4","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41586-024-08508-4"},{"id":"doi:10.1038/s41571-023-00811-9","kind":"review","title":"Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects","authors":["Edo Kon","Nitay Ad‐El","Inbal Hazan‐Halevy","Lior Stotsky‐Oterin","Dan Peer"],"author_count":5,"year":2023,"published":"2023-08-16","venue":"Nature Reviews Clinical Oncology","cited_by":376,"doi":"10.1038/s41571-023-00811-9","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41571-023-00811-9","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41571-023-00811-9"},{"id":"doi:10.1186/s12943-019-1055-6","kind":"review","title":"Neoantigen vaccine: an emerging tumor immunotherapy","authors":["Peng M","Mo Y","Wang Y","Wu P","Zhang Y","Xiong F"],"author_count":13,"year":2019,"published":"2019-08-23","venue":"Molecular cancer","cited_by":558,"doi":"10.1186/s12943-019-1055-6","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s12943-019-1055-6","archive_url":"https://space-kitty.com/papers/doi:10.1186/s12943-019-1055-6"},{"id":"doi:10.1172/jci134915","kind":"article","title":"mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer","authors":["Gal Cafri","Jared J. Gartner","Tal Z. Zaks","Kristen Hopson","Noam Levin","Biman C. Paria"],"author_count":19,"year":2020,"published":"2020-10-04","venue":"Journal of Clinical Investigation","cited_by":426,"doi":"10.1172/jci134915","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1172/jci134915","archive_url":"https://space-kitty.com/papers/doi:10.1172/jci134915"},{"id":"doi:10.1186/s12943-021-01348-0","kind":"review","title":"mRNA therapeutics in cancer immunotherapy","authors":["Jan David Beck","Daniel Reidenbach","Nadja Salomon","Uğur Şahin","Özlem Türeci","Mathias Vormehr"],"author_count":7,"year":2021,"published":"2021-04-15","venue":"Molecular Cancer","cited_by":385,"doi":"10.1186/s12943-021-01348-0","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s12943-021-01348-0","archive_url":"https://space-kitty.com/papers/doi:10.1186/s12943-021-01348-0"},{"id":"doi:10.3389/fimmu.2020.00369","kind":"review","title":"Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer","authors":["Picard E","Verschoor CP","Ma GW","Pawelec G"],"author_count":4,"year":2020,"published":"2020-03-06","venue":"Frontiers in immunology","cited_by":432,"doi":"10.3389/fimmu.2020.00369","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.3389/fimmu.2020.00369","archive_url":"https://space-kitty.com/papers/doi:10.3389/fimmu.2020.00369"},{"id":"doi:10.1038/s41591-024-02894-y","kind":"article","title":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial","authors":["Yarchoan M","Gane EJ","Marron TU","Perales-Linares R","Yan J","Cooch N"],"author_count":20,"year":2024,"published":"2024-04-07","venue":"Nature medicine","cited_by":225,"doi":"10.1038/s41591-024-02894-y","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41591-024-02894-y","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41591-024-02894-y"},{"id":"doi:10.1016/j.ymthe.2017.11.017","kind":"article","title":"Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses","authors":["Vogel AB","Lambert L","Kinnear E","Busse D","Erbar S","Reuter KC"],"author_count":13,"year":2018,"published":"2017-12-05","venue":"Molecular therapy : the journal of the American Society of Gene Therapy","cited_by":420,"doi":"10.1016/j.ymthe.2017.11.017","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.ymthe.2017.11.017","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.ymthe.2017.11.017"},{"id":"doi:10.1038/s41467-020-17409-9","kind":"article","title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","authors":["McKay PF","Hu K","Blakney AK","Samnuan K","Brown JC","Penn R"],"author_count":15,"year":2020,"published":"2020-07-09","venue":"Nature communications","cited_by":378,"doi":"10.1038/s41467-020-17409-9","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41467-020-17409-9","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41467-020-17409-9"},{"id":"doi:10.1021/acsnano.7b00978","kind":"review","title":"Efficient Nanovaccine Delivery in Cancer Immunotherapy","authors":["Guizhi Zhu","Fuwu Zhang","Qianqian Ni","Gang Niu","Xiaoyuan Shawn Chen"],"author_count":5,"year":2017,"published":"2017-03-09","venue":"ACS Nano","cited_by":374,"doi":"10.1021/acsnano.7b00978","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1021/acsnano.7b00978","archive_url":"https://space-kitty.com/papers/doi:10.1021/acsnano.7b00978"},{"id":"doi:10.1038/s41591-022-01937-6","kind":"article","title":"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results","authors":["Christine D. Palmer","Amy Rappaport","Matthew J. Davis","Meghan G. Hart","Ciaran D. Scallan","Sue‐Jean Hong"],"author_count":44,"year":2022,"published":"2022-08-01","venue":"Nature Medicine","cited_by":242,"doi":"10.1038/s41591-022-01937-6","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41591-022-01937-6","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41591-022-01937-6"},{"id":"doi:10.1038/s41591-024-02851-9","kind":"article","title":"A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results","authors":["Amy Rappaport","Chrisann Kyi","Monica Lane","Meghan G. Hart","Melissa Lynne Johnson","Brian S. Henick"],"author_count":38,"year":2024,"published":"2024-03-27","venue":"Nature Medicine","cited_by":158,"doi":"10.1038/s41591-024-02851-9","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41591-024-02851-9","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41591-024-02851-9"},{"id":"doi:10.1016/j.ymthe.2020.09.038","kind":"review","title":"Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities","authors":["Colby S. Shemesh","Joy Hsu","Iraj Hosseini","Ben‐Quan Shen","Anand Rotte","Patrick L. Twomey"],"author_count":8,"year":2020,"published":"2020-09-30","venue":"Molecular Therapy","cited_by":287,"doi":"10.1016/j.ymthe.2020.09.038","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.ymthe.2020.09.038","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.ymthe.2020.09.038"}],"newest_papers":[{"id":"doi:10.3390/vaccines14100874","kind":"review","title":"Navigating the Transition to RNA-Based Influenza Vaccines: A State-of-the-Art Review","authors":["Panagiotopoulos AP","Tsakri D","Laskaris A","Saldari C","Ranellou K","Mariolis I"],"author_count":8,"year":2026,"published":"2026-10-02","venue":"Vaccines","cited_by":0,"doi":"10.3390/vaccines14100874","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.3390/vaccines14100874","archive_url":"https://space-kitty.com/papers/doi:10.3390/vaccines14100874"},{"id":"doi:10.1039/d6bm00738d","kind":"review","title":"Advances in the development and delivery of nucleic acid-based therapeutics","authors":["Kurczewski E","Mansurov A","Sachar C","Guler MO"],"author_count":4,"year":2026,"published":"2026-09-29","venue":"Biomaterials science","cited_by":0,"doi":"10.1039/d6bm00738d","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1039/d6bm00738d","archive_url":"https://space-kitty.com/papers/doi:10.1039/d6bm00738d"},{"id":"doi:10.1038/s41467-026-77816-2","kind":"article","title":"Tuning intracellular immunity by Nodamura virus B2 protein enhances self-amplifying RNA activity","authors":["Sanchez-David RY","Nemegeer J","Le HD","Žusinaite E","Spiga L","Gonçalves A"],"author_count":9,"year":2026,"published":"2026-09-28","venue":"Nature communications","cited_by":0,"doi":"10.1038/s41467-026-77816-2","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41467-026-77816-2","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41467-026-77816-2"},{"id":"doi:10.1261/rna.081020.126","kind":"article","title":"Efficient production of a self-amplifying RNA vaccine sequence with the single subunit RNA polymerase from <i>Klebsiella</i> phage 32 utilizing the native AU initiating dinucleotide","authors":["Price MA","Trubitsyna M","Paget JE","Baker BW","Turner F","Rosser SJ"],"author_count":6,"year":2026,"published":"2026-09-16","venue":"RNA (New York, N.Y.)","cited_by":0,"doi":"10.1261/rna.081020.126","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1261/rna.081020.126","archive_url":"https://space-kitty.com/papers/doi:10.1261/rna.081020.126"},{"id":"doi:10.3390/ijms27188163","kind":"review","title":"Personalized mRNA Neoantigen Vaccines in Cancer: Linking Precision Antigen Selection, Immune Remodeling, and Checkpoint Blockade","authors":["Demircan T","Yıldırım B","Ünsal Hİ","Bilir A"],"author_count":4,"year":2026,"published":"2026-09-14","venue":"International journal of molecular sciences","cited_by":0,"doi":"10.3390/ijms27188163","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.3390/ijms27188163","archive_url":"https://space-kitty.com/papers/doi:10.3390/ijms27188163"},{"id":"doi:10.3390/vaccines14090781","kind":"review","title":"Research Progress, Application, and Industrialization Prospects of Circular RNA Vaccines in Viral Diseases","authors":["Cai D","Li X","Wang R","Lin C","Wen J","Tian B"],"author_count":6,"year":2026,"published":"2026-09-07","venue":"Vaccines","cited_by":0,"doi":"10.3390/vaccines14090781","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.3390/vaccines14090781","archive_url":"https://space-kitty.com/papers/doi:10.3390/vaccines14090781"},{"id":"doi:10.1126/sciadv.aeh9215","kind":"article","title":"Messenger RNA delivery of a dual CD25/CD122 affinity-tuned IL-2 variant prolongs exposure and potentiates antitumor T cell immunity","authors":["Vormehr M","Kranz LM","Muik A","Fellermeier-Kopf S","Beck JD","Eisel D"],"author_count":11,"year":2026,"published":"2026-09-04","venue":"Science advances","cited_by":0,"doi":"10.1126/sciadv.aeh9215","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1126/sciadv.aeh9215","archive_url":"https://space-kitty.com/papers/doi:10.1126/sciadv.aeh9215"},{"id":"doi:10.1016/j.biotechadv.2026.109028","kind":"review","title":"Generative AI-enabled neoantigen vaccine engineering: From tumor antigen discovery to personalized construct design and translational validation","authors":["Hu X","Liu X","Wang T","Yang G","Huang P","Xu H"],"author_count":6,"year":2026,"published":"2026-09-01","venue":"Biotechnology advances","cited_by":0,"doi":"10.1016/j.biotechadv.2026.109028","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.biotechadv.2026.109028","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.biotechadv.2026.109028"},{"id":"doi:10.1016/j.omtn.2026.103076","kind":"article","title":"Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8<sup>+</sup> T cells","authors":["Gold MJ","Millar DG","Liu J","Menon H","Karpov Y","Olsen K"],"author_count":15,"year":2026,"published":"2026-08-27","venue":"Molecular therapy. Nucleic acids","cited_by":0,"doi":"10.1016/j.omtn.2026.103076","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.omtn.2026.103076","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.omtn.2026.103076"},{"id":"doi:10.1038/s41467-026-76667-1","kind":"article","title":"A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial","authors":["Ottensmeier C","Delord JP","Lalanne A","Jamet C","Le Gac AL","Bidet Huang K"],"author_count":34,"year":2026,"published":"2026-08-17","venue":"Nature communications","cited_by":0,"doi":"10.1038/s41467-026-76667-1","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41467-026-76667-1","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41467-026-76667-1"}],"related_topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","api_url":"https://space-kitty.com/api/v1/topics/cancer-immunotherapy"},{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","api_url":"https://space-kitty.com/api/v1/topics/gene-editing-therapies"},{"slug":"gene-cell-therapy","name":"Gene & Cell Therapy","api_url":"https://space-kitty.com/api/v1/topics/gene-cell-therapy"},{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","api_url":"https://space-kitty.com/api/v1/topics/glp1-metabolic"},{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","api_url":"https://space-kitty.com/api/v1/topics/neurodegeneration"},{"slug":"aging-longevity","name":"Biology of Aging & Longevity","api_url":"https://space-kitty.com/api/v1/topics/aging-longevity"},{"slug":"infectious-disease-amr","name":"Infectious Disease, Vaccines & Antimicrobial Resistance","api_url":"https://space-kitty.com/api/v1/topics/infectious-disease-amr"},{"slug":"ai-medicine","name":"AI in Clinical Medicine","api_url":"https://space-kitty.com/api/v1/topics/ai-medicine"},{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","api_url":"https://space-kitty.com/api/v1/topics/cardiovascular-innovation"}],"premium":{"dossier":null,"research_pack":{"url":"https://space-kitty.com/api/v1/topics/mrna-cancer-vaccines/pack","price_usd":"0.20"}},"more":"https://space-kitty.com/api/v1/topics/mrna-cancer-vaccines/papers?sort=top&limit=100"}